This Commentary piece explores how the production and delivery of NK cells could provide a new option for clinical treatment of illnesses such as myeloid leukaemia, with the potential for scaling approaches to be incorporated into the treatment process.

Emerging experts in the field of cell therapy: Emily Warner, Moin Saleem, and John Maher, answer questions about their science and industry

Oxford Global’s Discussion Groups provide a focused networking opportunity for a handful of like-minded experts on a monthly basis. Our November Discussion Group addressing ‘Advancing The Implementation Of Automation Technologies For Cell Therapy Development’ was a tremendous success. The discussion brought together an exclusive panel of key opinion leaders to address the key factors behind the market’s growth, its priorities, future outlook, and challenges.

What does the future of the vaccine look like? Tony D’Amore and Yan-Ping Yang of Sanofi Pasteur take us through the ever-evolving vaccine development and manufacturing landscape.

What are the key market trends and challenges facing the Gene Therapy industry today? We sat down with an advisory group of leading pharmaceutical and biotechnology experts to discuss our latest Gene Therapy Congress and the exciting insights it disclosed.

Presented by Krzysztof Inglot, Technical Sales Specialist, Thermo Fisher Scientific | Femi Egbebi, Senior Global Product Manager, Thermo Fisher Scientific | Daniel Merriman, Strategic Marketing Manager, Thermo Fisher Scientific

Video Interview | Joachim Baer, Director of Cell Culture Development at Boehringer Ingelheim

Q&A with Ulrich Rümenapp Head of Launch Preparation and Coordination, Product Supply Biotech, Bayer AG

Q&A with Rosemary Versteegen, PhD Chief Executive Officer, International Serum Industry Association

Ron Bates, Director, Bristol-Myers Squibb